ENDOSCOPIC AND CLINICAL EFFICACY DEMONSTRATED WITH ORAL OZANIMOD IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Brian G. Feagan 1
William Sandborn 2
Geert R. D'Haens 3
Barrett G. Levesque 1
Brett E. Skolnick 4
Caiyan Li 5
Darryl Penenberg
Richard Aranda
Allan Olson
1 Robarts Research Institute,London,Canada
2 University of California,Division of Gastroenterology,La Jolla, San Diego,United States of America
3 Academic Medical Center,Amsterdam,Netherlands
4 Receptos, a wholly owned subsidiary of Celgene,San Diego,United States of America
5 Receptos, a wholly-own
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]